Farhat L, Besbes M, Bridier A, Kaffel F, Daoud J. [Quality control of dosing delivered by in vivo measurements for head and neck radiotherapy].
Cancer Radiother 2009;
14:69-73. [PMID:
19695937 DOI:
10.1016/j.canrad.2009.05.007]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/17/2008] [Revised: 04/15/2009] [Accepted: 05/02/2009] [Indexed: 10/20/2022]
Abstract
PURPOSE
Measurement of absorbed dose in target volume is widely considered to be an important tool for quality assurance in external radiotherapy. The aims of this work were to measure the entrance dose for patient treated for head and neck tumors and to compare this measured dose with the dose calculated.
PATIENTS AND METHODS
Twenty patients were evaluated. Initially, the measurements were performed on a polystyrene phantom in order to calibrate diodes in terms of entrance dose and to determinate appropriate correction factors. In vivo entrance dosimetry check was performed for these patients treated for head and neck tumors in (60)Co gamma-rays.
RESULTS
For the entrance dose evaluation over 100 field measurements, the mean deviation between the measured dose and the calculated dose was equal to 0.12% and the standard deviation was 1.84%. The deviation was less than 3% in 95% of measurements. Large deviation (more than 5%) was observed in one case.
CONCLUSION
Simple in vivo dose measurements are an additional safeguard against major set-up errors and calculation or transcription errors that were missed during pretreatment chart check.
Collapse